Exceptional response to alectinib for duodenal carcinoma with ALK fusion: A case report and literature review

Patients with advanced duodenal carcinoma usually have a poor prognosis due to limited effective chemotherapy options. The study for genotype-directed therapy in patients with duodenal carcinoma is progressing. However, no clinical data assessing the efficacy of molecularly targeted therapy are pres...

Descripción completa

Detalles Bibliográficos
Autores principales: Isaka, Yuri, Sasaki, Akinori, Saito, Akira, Motomura, Yasuaki, Ando, Yayoi, Nakamura, Yoshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878825/
https://www.ncbi.nlm.nih.gov/pubmed/36713517
http://dx.doi.org/10.3389/fonc.2022.1064944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878825/
https://www.ncbi.nlm.nih.gov/pubmed/36713517
http://dx.doi.org/10.3389/fonc.2022.1064944

Ejemplares similares